These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32114594)

  • 1. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
    Arain SA; Arafah M; Said Raddaoui EM; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
    Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not All Cases of Mammary Paget's Disease are Cytokeratin-7 Positive: A Challenging Diagnosis!
    Anja K; Hélène D; Pascal VE; Liliane M; Mieke VB
    Int J Surg Pathol; 2021 Sep; 29(6):631-634. PubMed ID: 33750236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7-negative mammary Paget's disease: A diagnostic pitfall.
    Ozerdem U; McNiff JM; Tavassoli FA
    Pathol Res Pract; 2016 Apr; 212(4):279-81. PubMed ID: 26944832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Useful immunohistochemical markers for distinguishing Paget cells from Toker cells.
    Park S; Suh YL
    Pathology; 2009; 41(7):640-4. PubMed ID: 20001343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
    Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
    Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
    Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells.
    Lundquist K; Kohler S; Rouse RV
    Am J Surg Pathol; 1999 Feb; 23(2):212-9. PubMed ID: 9989849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
    Liu W; Iqbal J; Khoury T
    J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepidermal cytokeratin 7 immunoreactive cells in the non-neoplastic nipple may represent interepithelial extension of lactiferous duct cells.
    Yao DX; Hoda SA; Chiu A; Ying L; Rosen PP
    Histopathology; 2002 Mar; 40(3):230-6. PubMed ID: 11895488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive mammary Paget's disease without an underlying breast carcinoma.
    Hanna M; Jaffer S; Bleiweiss IJ; Nayak A
    Virchows Arch; 2013 Sep; 463(3):471-3. PubMed ID: 23851623
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine diagnosis of mammary Paget's disease. A modern approach.
    Hitchcock A; Topham S; Bell J; Gullick W; Elston CW; Ellis IO
    Am J Surg Pathol; 1992 Jan; 16(1):58-61. PubMed ID: 1370192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
    Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
    Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary Paget's Disease of the Male Breast: A Rare Case With an Unusual Immunohistochemical Profile.
    Moore SA; Notgrass HM; Vandergriff TW; Sahoo S
    Int J Surg Pathol; 2020 Apr; 28(2):210-215. PubMed ID: 31514589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocrine gland carcinoma of the mammary skin concomitant with pagetoid phenomenon.
    Usui K; Ochiai T; Abe I; Nishio H; Togo K; Yamagata M
    J Dermatol; 2010 Apr; 37(4):350-4. PubMed ID: 20507405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
    Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
    Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.
    Lu S; Yakirevich E; Wang LJ; Resnick MB; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1085. PubMed ID: 31718619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget's disease of the nipple in a Her2-positive breast cancer xenograft model.
    Drews-Elger K; Sandoval-Leon AC; Ergonul AB; Jegg AM; Gomez-Fernandez C; Miller PC; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2020 Feb; 179(3):577-584. PubMed ID: 31720992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
    J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.